Suppr超能文献

全身型幼年特发性关节炎患者巨噬细胞活化综合征的评估:单中心经验

Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience.

作者信息

Høeg Pia Elkjær, Glerup Mia, Mahler Birgitte, Høst Christian, Herlin Troels

机构信息

Pediatric Rheumatology Clinic, Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Denmark.

Diagnostic Center, Regional Hospital Silkeborg, Silkeborg, Denmark.

出版信息

Int J Rheumatol. 2022 Jul 27;2022:1784529. doi: 10.1155/2022/1784529. eCollection 2022.

Abstract

OBJECTIVES

Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile arthritis (sJIA), and early diagnosis is critical for survival. The objective of this study was to evaluate the 2016 MAS classification criteria in a Danish sJIA cohort and to compare different sets of criteria for the early identification of MAS including the HLH-2004 diagnostic guidelines, MS score, and the ferritin/ESR ratio.

METHODS

Data was extracted from medical charts of 32 patients with sJIA from a single Danish paediatric rheumatology center diagnosed between January 2014 and June 2021. Patients who met the 2016 MAS classification criteria were classified as having MAS. From a receiver operating characteristic (ROC) plot, the area under the curve (AUC) was calculated for the prediction of patients with MAS according to the 2016 MAS classification criteria using either MS score or the ferritin/ESR ratio.

RESULTS

Of the cohort, eight (25%) patients were classified as having MAS according to the 2016 MAS classification criteria compared to only three (9.4%) patients fulfilling the HLH-2004 diagnostic guidelines, all of which had recurrent MAS. The ferritin/ESR ratio showed the highest sensitivity (100%) but the lowest specificity (72.2%). In comparison, the MS score had a higher specificity (90.9%) for the identification of MAS according to the 2016 classification criteria. In our cohort, the most optimal cut-off point for the ferritin/ESR ratio was ≥19.4 (sensitivity: 100%, specificity: 72.2%) and ≥ -1.5 for the MS score (sensitivity: 71.4%, specificity: 91.7%), respectively.

CONCLUSION

The 2016 MAS classification criteria were a valuable tool in the discrimination of sJIA with and without MAS. The HLH-2004 diagnostic guidelines showed the lowest sensitivity, ferritin/ESR ratio, and the lowest specificity compared to the MS score where an acceptable high sensitivity and specificity was found.

摘要

目的

巨噬细胞活化综合征(MAS)是系统性幼年特发性关节炎(sJIA)的严重并发症,早期诊断对存活至关重要。本研究的目的是在丹麦sJIA队列中评估2016年MAS分类标准,并比较包括HLH-2004诊断指南、MS评分和铁蛋白/血沉比值在内的不同标准集对MAS的早期识别情况。

方法

从丹麦一家儿科风湿病中心2014年1月至2021年6月诊断的32例sJIA患者的病历中提取数据。符合2016年MAS分类标准的患者被分类为患有MAS。根据接受者操作特征(ROC)曲线,使用MS评分或铁蛋白/血沉比值,根据2016年MAS分类标准计算预测MAS患者的曲线下面积(AUC)。

结果

在该队列中,根据2016年MAS分类标准,8例(25%)患者被分类为患有MAS,而只有3例(9.4%)患者符合HLH-2004诊断指南,所有这些患者均有复发性MAS。铁蛋白/血沉比值显示出最高的敏感性(100%)但最低的特异性(72.2%)。相比之下,根据2016年分类标准,MS评分在识别MAS方面具有更高的特异性(90.9%)。在我们的队列中,铁蛋白/血沉比值的最佳截断点分别为≥19.4(敏感性:100%,特异性:72.2%)和MS评分为≥ -1.5(敏感性:71.4%,特异性:91.7%)。

结论

2016年MAS分类标准是鉴别有或无MAS的sJIA的有价值工具。与MS评分相比,HLH-2004诊断指南显示出最低的敏感性、铁蛋白/血沉比值和最低的特异性,而MS评分具有可接受的高敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82c2/9348923/aa72cfd0b4a2/IJR2022-1784529.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验